Showing results (121-130 of 177) with videos related to

Sort By:
Pageof 18
Proceedings of the National Academy of Sciences of the United States of America|March 28, 1995
Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccineK Kitamura, P O Livingston, S R Fortunato, et al.
The Journal of Experimental Medicine|September 19, 1979
Cell surface antigens of human renal cancer defined by autologous typingR Ueda, H Shiku, M Pfreundschuh, et al.
Cancer Research|September 1, 1985
Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissuesF X Real, A N Houghton, A P Albino, et al.
Cancer|February 15, 1985
Serological response of melanoma patients to vaccines prepared from VSV lysates of autologous and allogeneic cultured melanoma cellsP O Livingston, A P Albino, T J Chung, et al.
Cancer Research|January 1, 1986
Immunological variables as predictors of prognosis in patients with Kaposi's sarcoma and the acquired immunodeficiency syndromeS Vadhan-Raj, G Wong, C Gnecco, et al.
Somatic Cell and Molecular Genetics|May 1, 1984
Two cell-surface markers for human chromosome 1 in interspecies hybridsW J Rettig, N C Dracopoli, T A Goetzger, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Endotoxin-induced tumor necrosis factorH F Oettgen, E A Carswell, R L Kassel, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1986
Specificity analysis of human monoclonal antibodies reactive with cell surface and intracellular antigensR J Cote, D M Morrissey, A N Houghton, et al.
International Journal of Cancer|January 21, 1991
Blood group and blood-group-related antigens in normal pancreas and pancreas cancer: enhanced expression of precursor type 1, Tn and sialyl-Tn in pancreas cancerM H Schuessler, S Pintado, S Welt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trialH W Herr, D M Schwalb, Z F Zhang, et al.
Pageof 18